Akkure
PrivateLast Round
Grant
Nov 21, 2022
Est. Valuation
$6.27M
Total Funding Raised
$3.6M
Company Overview
Akkure operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Grant round in November 2022.
Akkure is a health technology company that provides an AI-powered platform for clinical trial recruitment and genomic data analytics.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akkure Comparables
Compare Akkure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ancora.ai | 82% | |
| Massive Bio | 78% | |
| Power | 76% |
For institutional investors. Book with your work email.
Akkure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 21, 2022 | ||||
| Crowdfunding | Nov 21, 2022 | ||||
| Crowdfunding | Feb 11, 2021 | ||||
| Grant | Dec 1, 2019 |
For institutional investors. Book with your work email.
Akkure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Department of Enterprise, Trade and Employment | Grant |
| Spark Venture Funding | Crowdfunding |
| Enterprise Ireland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2022
$1M raised from Spark Venture Funding.
- Nov 21, 2022
$710K raised from Department of Enterprise, Trade and Employment.
For institutional investors. Book with your work email.
Akkure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Akkure's valuation, stock price, and market status.
Is Akkure a public or private company?
Akkure is a private company.
What is the current stock price of Akkure?
Akkure is a private company, so its shares have no public market price. Caplight tracks Akkure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Akkure worth (valuation)?
Akkure's valuation is estimated at $6.3M based on funding round data.
Can I buy Akkure stock?
Akkure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Akkure's last funding round?
Akkure's most recent funding round was Grant on November 21, 2022.
Who are the main investors in Akkure?
Key investors in Akkure include Department of Enterprise, Trade and Employment, Spark Venture Funding, Enterprise Ireland.
Will Akkure IPO soon?
No public IPO plans have been announced for Akkure.
How can I track Akkure secondary market activity?
Caplight tracks bids, offers, and trades in Akkure's shares on secondary markets.